BLOG - Nimble Diagnostics

Updates
73

NIMBLE I

NIMBLE-I We are excited to share that NIMBLE-I, our first-in-human clinical study, is now officially completed. Fifty-six patients were enrolled at the Hospital Universitari Germans Trias i Pujol (Can Ruti) in Badalona, Spain, marking an important milestone in the journey of the WAEVE® System from laboratory prototype to clinical reality. The Problem Every year, hundreds of thousands of patients undergo coronary stent implantation to treat blocked arteries. While stents are life-saving, living with one is not without uncertainty. In-stent restenosis (ISR), the re-narrowing of the artery inside the stent, affects between 5% and 10% of all patients with a stent. Aside restenosis, stent fractures and other structural complications add …

Meet the team
103

Introducing Montse Gutiérrez: Regulatory Affairs and Quality Assurance Director

At NIMBLE, every team member brings a distinct perspective to the table. Today, we’re spotlighting Montse Gutiérrez, our RAQA Director, who joined us in April 2025. Her role sits at the crossroads of innovation and compliance, to ensure NIMBLE’s vision can actually reach patients, legally, safely, and credibly. Since joining, Montse has established the quality and regulatory framework that underpins product development, clinical investigations, and the company’s path toward global market access. That includes early involvement in the FDA Breakthrough Device Designation program and the regulatory work required to obtain …

Meet the team
158

Introducing David Anguiano: Senior Telecommunications Engineer

At NIMBLE, every team member brings a distinct perspective to the table. Today, we’re spotlighting David Anguiano, our Senior Telecommunications Engineer, who works at the intersection of radio frequency (RF) engineering and medical technology, a combination that sits at the heart of what NIMBLE is building. Since joining the team, David has taken on the electromagnetic and antenna design side of the technology, covering everything from simulation and microwave measurements to signal analysis in real-world testing conditions. One of his most significant contributions has been the redesign of the transducer …

Introducing Pol Gómez: Chief Medical Officer

At NIMBLE, every team member contributes uniquely to our mission of turning innovative ideas into real clinical solutions. Today, we’re spotlighting Pol Gómez, our Chief Medical Officer, who joined NIMBLE in January 2023. Pol brought with him a wealth of experience from both the clinical and research worlds, combining his work in cardiology clinical trials with his background as an administrator in the Cardiology Research Group (ICREC) at the IGTP Foundation, where NIMBLE was born. One of his key contributions has been coordinating the process that led to the AEMPS …

News
372

From your kitchen to Clinical Settings

Microwaves don't just heat food: they detect tumors, guide cancer therapies, and monitor stents with zero radiation. Discover how this technology is reshaping modern medicine. The solution: Waeve system.

News
803

Welcoming Prof. Dr. Morton J. Kern to our Team

NIMBLE is delighted to announce that Prof. Dr. Morton J. Kern, MD, a leading clinician in interventional cardiology, has joined our Medical Advisory Board. His expertise will play a pivotal role in guiding our clinical strategy, particularly as we prepare for entry into the US market and pursue FDA approval. Background: Dr. Kern is a Professor of Medicine at the University of California, Irvine in the Division of Cardiology. He is also Chief of Cardiology at the Long Beach Veterans Administration Medical Center. Dr Kern received his medical degree …

News
17

Recovery After Heart Attack and Stents: A Comprehensive Guide

A heart attack occurs when blood flow through one or more of the arteries that supply the heart, known as the coronary arteries, is impeded by a blockage. This blockage can damage the heart muscle, so immediate treatment is important. After a heart attack, a stent may be inserted into the blocked artery to restore and maintain blood flow. Understanding the recovery time after heart stent placement is key for effective healing. This guide outlines the recovery process, including the timeline and necessary lifestyle changes. How long does heart attack …

News
25

How Long Do Coronary Stents Last and Factors That Influence Their Lifespan

Coronary stents are life-saving 'implants used to treat coronary artery disease (CAD) by maintaining open arteries and ensuring adequate blood flow to the heart. Understanding the longevity of heart stents and the factors that influence their lifespan is crucial for patients and healthcare providers to manage expectations and optimize outcomes. (E.g.) Published 18 June 2024 Reviewed by: Oriol Rodriguez, MD. Interventional Cardiologist at Hospital Germans Tries i Pujol, Badalona, ES. How Long Do Coronary Stents Last? Factors That Influence Their Lifespan Coronary stents are life-saving implants used to treat coronary …

News
2

Cardiac diagnostic imaging: understanding angiography

Reviewed by Dr. J.M. Montero-Cabezas, Interventional Cardiology Department, Leiden University Medical Center (LUMC) Cardiac diagnostic imaging is a critical component of modern cardiovascular medicine. These tests are vital to healthcare providers, as they reveal symptoms and allow for the diagnosis and management of heart-related ailments. In its early practice, cardiac imaging mainly consisted of catheterization and angiography. However, in recent decades, testing has evolved to become less invasive and more sophisticated. By evaluating the strengths and applications of each form of cardiac diagnostic imaging, tests can be applied more practically …

NIMBLE Diagnostics Featured at Hello Tomorrow Global Summit in Paris!

We are thrilled to share the success of NIMBLE Diagnostics at the exciting Hellow Tomorrow Global Summit, held from March 21st to 22nd, 2024, in Paris. This event brought together top experts in the medical device space, healthcare startups, global investors, and European governmental figures for a dynamic exchange of ideas and opportunities. Throughout the summit, we had the privilege of engaging with investors from around the globe, showcasing our NIMBLE System, and participating in panel discussions and presentations. We had the opportunity to share broadly our vision for the …

Introducing Naia Jiménez Polo: Business Development Manager

NIMBLE is a company that thrives on the unique contributions of each of its associates. To learn more about their personal motivations and recognize their unique contributions, we are taking the time to spotlight each incredible member of our team. Naia Jiménez Polo has been the Business Development Manager at NIMBLE for just two months, but she has already invested herself in the brand mission and made invaluable contributions to our cause. Background In her early education, Naia was always interested in the sciences: everything from biology to physics …

NIMBLE Diagnostics attends the 2024 Mobile World Congress in Barcelona

NIMBLE Diagnostics wrapped up its successful debut appearance at last week’s #MWC24 in Barcelona. The conference’s 10th year anniversary held over 100,000 attendees, and 2,700 exhibitors, sponsors, and partners. The #4YFN space provided an exceptional platform to introduce our vision to the local authorities, corporations and customers about how the NIMBLE System aims to prevent major #coronary ischemic events. We look forward to continuing this journey, driving innovation, and shaping the future of healthcare. …

All Blog Posts